MedWellAI, Inc. SEC 10-Q Report
I'm LongbridgeAI, I can summarize articles.MedWellAI, Inc. has released its Form 10-Q report for Q4 2025, indicating a strategic shift from digital asset mining to AI-driven healthcare solutions. Key financial highlights include a decrease in commission and online sales revenues, while product sales surged to $522,798. The net loss attributable to shareholders improved to $939,397. The company operates through subsidiaries like MedWell USA and MedWell Facilities, focusing on pharmaceutical distribution and real estate in healthcare. Future plans include expanding AI-driven healthcare solutions and consolidating preferred stock.
MedWellAI, Inc., formerly known as Integrated Ventures, Inc., has released its Form 10-Q report for the fourth quarter of 2025. The report highlights the company's strategic shift from digital asset mining to AI-driven healthcare and wellness solutions, alongside significant changes in its financial and operational performance.
Financial Highlights
- Revenues from commissions: $2,623 for the three months ended December 31, 2025, decreased from $133,272 in the same period in 2024, due to a shift in focus to product sales.
- Revenues from online sales: $394 for the three months ended December 31, 2025, decreased from $9,589 in the same period in 2024, as the company exited online sales due to regulatory hurdles.
- Revenues from product sales: $522,798 for the three months ended December 31, 2025, increased from $0 in the same period in 2024, reflecting a strategic shift to product sales.
- Rental income: $22,500 for the three months ended December 31, 2025, increased from $0 in the same period in 2024, due to a new sublease agreement.
- Net Loss Attributable to shareholders: $939,397 for the six months ended December 31, 2025, improved from $1,889,958 in the same period in 2024, as the company transitioned from digital asset mining to health and wellness.
Business Highlights
- Company Overview: MedWellAI, Inc. is a diversified holdings company focused on AI-driven healthcare and wellness solutions. The company operates through subsidiaries like MedWell USA, a B2B e-commerce platform for pharmaceutical distribution, and MedWell Facilities, which focuses on real estate opportunities in the health and wellness sector.
- Business Focus Shift: The company has shifted its focus from digital asset mining to product sales in the healthcare and wellness industry, particularly GLP medications for weight loss and diabetes management.
- Subsidiary Operations: MedWell USA operates an AI-powered ordering system for pharmaceutical products, providing real-time inventory tracking and smart suggestions for healthcare providers. MedWell Facilities is dedicated to developing real estate opportunities to attract healthcare providers and wellness clinic operators.
- Acquisition: On August 29, 2024, the company acquired 51% of the membership interests in Healthy Lifestyle USA LLC, a Florida-based company, through its subsidiary MedWell Direct.
- Revenue Segments: The company reported revenue from product sales, commissions, and rental income. Product sales have become a significant focus, with substantial increases in revenue compared to the previous year.
- Operational Changes: The company exited online sales due to regulatory hurdles and discontinued its digital asset mining operations, marking a strategic shift towards healthcare and wellness.
- Recent Developments: Effective August 1, 2025, the company consolidated its Series C and D Preferred Stock into a single series of convertible preferred stock, retiring $2,133,081 in accrued and unpaid dividends.
- Future Outlook: The company aims to continue its focus on AI-driven healthcare solutions and expand its presence in the health and wellness industry, leveraging its subsidiaries to drive growth and operational efficiency.
SEC Filing: MedWellAI, Inc. [ MWAI ] - 10-Q - Feb. 23, 2026